The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: detection of mutated TMPRSS2 form in a case of aggressive disease.
about
Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteinsThe membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cellsTMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesionsInfluenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tractsCleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitorsInhibition of human matriptase by eglin c variants.Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status.Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosisTMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cellsPhenotypic analysis of mice lacking the Tmprss2-encoded proteaseDifferentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines.Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden.The influence of sex steroids on Sjögren's syndrome.Recurrent gene fusions in prostate cancerProstatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).Translocations in epithelial cancers.TMPRSS2, a novel membrane-anchored mediator in cancer pain.Urine markers in monitoring for prostate cancer.The genomic landscape of prostate cancerTMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer.The role of type II transmembrane serine protease-mediated signaling in cancer.miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.In vitro characterization of TMPRSS2 inhibition in IPEC-J2 cells.Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.Transmembrane protease serine 2 in prostate cancer.Cloning, expression, and regulation by androgens of a putative member of the oxytocinase family of proteins in the rat prostate.Genomic predictors of prostate cancer therapy outcomes.Hypermethylation-mediated transcriptional repression of TMPRSS2 in androgen receptor-negative prostate cancer cells.Serotonergic regulation of melanocyte conversion: A bioelectrically regulated network for stochastic all-or-none hyperpigmentation.Differential expression of AP-1 transcription factors in human prostate LNCaP and PC-3 cells: role of Fra-1 in transition to CRPC status.
P2860
Q24302437-DB3DFDCD-6B7F-493A-857D-219E94AA921BQ24534541-787746D9-5C7D-485C-9328-1FBCF1AA0B67Q24678489-1D5BD0B4-9DDA-46EA-A4C1-23C4A79D69F9Q28730201-948B172B-5BCF-491C-8170-342D9390083FQ30386796-1A00B140-7A45-456B-A530-C4FB2559A754Q33237770-2E882C23-A899-409E-8266-272D304A1FA9Q33645816-E61B8EA1-1CC2-4BC6-9ACA-7DD8669622FDQ33865984-8A5444B8-925F-4FA1-9C07-30DC431A0410Q33882562-19AF4DB1-FF09-4D6E-A291-A6041E4E136BQ34302430-2C1920E3-FED3-4749-9AA0-500A6F054A00Q35873154-4EB52343-B68A-4608-8823-DC5BD7C49B34Q36265498-417688B3-0FB6-42EE-85F2-78BBB8D41FDBQ36545204-FD84E238-637D-4C98-9176-0FD9590FFEDDQ36951058-6E0CF9A7-797D-4925-99FE-C014F1B18100Q37194503-66EEB498-32F8-4D08-B75B-12683B413EB5Q37216570-99E9F56F-846D-4B07-99CB-082D13A61129Q37363960-9AFABD88-B74D-4F3E-8E45-9CB9CDAC5A53Q37560019-F51ABACD-60B2-48F4-A06A-A42C4A214785Q37571461-C0B525A2-6634-431D-BE66-87363568F000Q38109474-5776A48B-7FC9-4E1C-BA0A-A220F24FDF67Q38805821-0E05AEAC-0393-4D74-9D0F-21C125D61AFCQ39015415-5CE26D11-FFBE-40C7-9F2A-C307D0AE79B9Q39214638-480CFDC6-D04A-42EF-B93E-92C8BC405AA7Q40274276-E6C68873-8550-4A2D-A900-305796BCD14DQ40640375-86EF0178-F837-4C50-9930-74485CE11B14Q40685677-835C0BAB-B5CF-4B31-8A99-364D35FE32F8Q43076015-9FEF0506-1F86-409A-808F-23D8F27C3013Q44184350-71F3AA9B-1235-41F8-B17E-05E3BF50E532Q44958045-F4A8698B-F50B-4B68-9472-BCAE9A94C317Q45753064-48C8CB89-0C7B-4148-861A-3CA1174AFDD6Q45953239-561D77CB-3824-4EC1-9CB4-ECF82DCFC54AQ51067963-6B82C015-2D1E-410B-AB9D-26B096319897
P2860
The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: detection of mutated TMPRSS2 form in a case of aggressive disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The TMPRSS2 gene encoding tran ...... a case of aggressive disease.
@en
The TMPRSS2 gene encoding tran ...... a case of aggressive disease.
@nl
type
label
The TMPRSS2 gene encoding tran ...... a case of aggressive disease.
@en
The TMPRSS2 gene encoding tran ...... a case of aggressive disease.
@nl
prefLabel
The TMPRSS2 gene encoding tran ...... a case of aggressive disease.
@en
The TMPRSS2 gene encoding tran ...... a case of aggressive disease.
@nl
P2093
P2860
P356
P1476
The TMPRSS2 gene encoding tran ...... n a case of aggressive disease
@en
P2093
P2860
P304
P356
10.1002/IJC.1526
P577
2001-12-01T00:00:00Z